Younger patients with remitted primary anterior uveitis are at a higher risk of relapsing

Article

Young adults with remitted primary anterior uveitis pose a higher risk of relapsing than middle-aged adults.

Young adults with remitted primary anterior uveitis pose a higher risk of relapsing than middle-aged adults, according to an investigation featured in Ophthalmology.

Dr John H. Kempen et al., Department of Ophthalmology, The University of Pennsylvania, Philadelphia, Pennsylvania, USA, compiled at retrospective cohort study on 102 anterior uveitis patients. Each patient achieved remission during the primary episode of anterior uveitis within 90 days of diagnosis. Information was obtained via a standardized chart review and the main outcome measures included time to relapse of anterior uveitis and the risk factors contributing towards relapse.

The findings demonstrated a recurrence of anterior uveitis in 40 patients and a relapse incidence in 24% per patient, per year. Of the patients studied, 61% remained in remission at 1.5 years after remission.

A ratio of 18 to 35 year old patients vs. 35 to 55 year old patients revealed that younger adults presented with a significantly higher relapse risk than middle-aged adults.

The study suggests an explicit plan should be formulated for detecting and managing relapses in patients with primary anterior uveitis.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
© 2025 MJH Life Sciences

All rights reserved.